These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17685872)

  • 1. Novel treatments for cancer cachexia.
    Bossola M; Pacelli F; Doglietto GB
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cachexia: it's time for more clinical trials.
    Bossola M; Pacelli F; Tortorelli A; Doglietto GB
    Ann Surg Oncol; 2007 Feb; 14(2):276-85. PubMed ID: 17094025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of cancer cachexia: new insights into an old problem.
    Muscaritoli M; Bossola M; Aversa Z; Bellantone R; Rossi Fanelli F
    Eur J Cancer; 2006 Jan; 42(1):31-41. PubMed ID: 16314085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle in cancer cachexia: the ideal target of drug therapy.
    Bossola M; Pacelli F; Tortorelli A; Rosa F; Doglietto GB
    Curr Cancer Drug Targets; 2008 Jun; 8(4):285-98. PubMed ID: 18537552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials.
    Molfino A; Amabile MI; Giorgi A; Monti M; D'Andrea V; Muscaritoli M
    Expert Opin Investig Drugs; 2019 Aug; 28(8):733-740. PubMed ID: 31347405
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer cachexia: molecular mechanism and pharmacological management.
    Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
    Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel investigational drugs mimicking exercise for the treatment of cachexia.
    Penna F; Pin F; Ballarò R; Baccino FM; Costelli P
    Expert Opin Investig Drugs; 2016; 25(1):63-72. PubMed ID: 26560328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
    Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
    Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
    Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
    Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and treatment of cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S19-24. PubMed ID: 22749678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):5-9. PubMed ID: 22229463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer anorexia-cachexia syndrome: current issues in research and management.
    Inui A
    CA Cancer J Clin; 2002; 52(2):72-91. PubMed ID: 11929007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia.
    Penna F; Costelli P
    Expert Opin Investig Drugs; 2019 Feb; 28(2):179-189. PubMed ID: 30526137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and treatment of cancer anorexia-cachexia, with special emphasis on aged patients].
    Inui A
    Nihon Ronen Igakkai Zasshi; 2004 Sep; 41(5):460-7. PubMed ID: 15515719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.